Financial Network Wealth Management LLC Has $1.34 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Financial Network Wealth Management LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,649 shares of the healthcare conglomerate’s stock after selling 451 shares during the quarter. Financial Network Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,340,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $512.30 on Friday. The firm has a market cap of $468.61 billion, a PE ratio of 33.05, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s fifty day simple moving average is $510.24 and its two-hundred day simple moving average is $547.97.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the company posted $5.83 EPS. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.